Abstract
The expression of proteins which do not express well on their own can be enhanced by linking them to human serum albumin (HSA) or antibody crystallizable fragment (Fc). The constructs shown here are designed to secrete the proteins after transient transfection of mammalian cell lines. The fusion partners are appended to the N-terminus of the proteins and contain a linker designed to be proteolytically cleaved. Transient transfection and purification protocols are provided as well as experimental results with five interleukins.
Keywords: Fusion proteins, protein expression, transfection, 2936E cells, polyethyleneimine, PEI
Current Pharmaceutical Biotechnology
Title: Fusion Partners as a Tool for the Expression of Difficult Proteins in Mammalian Cells
Volume: 11 Issue: 3
Author(s): Jue Zhang, Jane Carter, Sophia Siu, Jason W. O'Neill, Andrew H. Gates, John Delaney and Christopher Mehlin
Affiliation:
Keywords: Fusion proteins, protein expression, transfection, 2936E cells, polyethyleneimine, PEI
Abstract: The expression of proteins which do not express well on their own can be enhanced by linking them to human serum albumin (HSA) or antibody crystallizable fragment (Fc). The constructs shown here are designed to secrete the proteins after transient transfection of mammalian cell lines. The fusion partners are appended to the N-terminus of the proteins and contain a linker designed to be proteolytically cleaved. Transient transfection and purification protocols are provided as well as experimental results with five interleukins.
Export Options
About this article
Cite this article as:
Zhang Jue, Carter Jane, Siu Sophia, W. O'Neill Jason, H. Gates Andrew, Delaney John and Mehlin Christopher, Fusion Partners as a Tool for the Expression of Difficult Proteins in Mammalian Cells, Current Pharmaceutical Biotechnology 2010; 11 (3) . https://dx.doi.org/10.2174/138920110791111898
DOI https://dx.doi.org/10.2174/138920110791111898 |
Print ISSN 1389-2010 |
Publisher Name Bentham Science Publisher |
Online ISSN 1873-4316 |
Call for Papers in Thematic Issues
Artificial Intelligence in Bioinformatics
Bioinformatics is an interdisciplinary field that analyzes and explores biological data. This field combines biology and information system. Artificial Intelligence (AI) has attracted great attention as it tries to replicate human intelligence. It has become common technology for analyzing and solving complex data and problems and encompasses sub-fields of machine ...read more
- Author Guidelines
- Graphical Abstracts
- Fabricating and Stating False Information
- Research Misconduct
- Post Publication Discussions and Corrections
- Publishing Ethics and Rectitude
- Increase Visibility of Your Article
- Archiving Policies
- Peer Review Workflow
- Order Your Article Before Print
- Promote Your Article
- Manuscript Transfer Facility
- Editorial Policies
- Allegations from Whistleblowers
Related Articles
-
A Key Role for Connexin Hemichannels in Spreading Ischemic Brain Injury
Current Drug Targets The Application of Rational Design on Phospholipase A2 Inhibitors
Current Medicinal Chemistry The Aromatic Stacking Interactions Between Proteins and their Macromolecular Ligands
Current Protein & Peptide Science A Novel Prescription for Alzheimer’s Disease: Targeting Hypercoagulable States
Current Neurovascular Research A Pilot Study on Prostate Cancer Risk and Pro-Inflammatory Genotypes: Pathophysiology and Therapeutic Implications
Current Pharmaceutical Design Immunotherapy for Uveal Melanoma - Current Knowledge and Perspectives
Current Medicinal Chemistry Pharmacogenomics and Sepsis-Induced Renal Failure: Effects of β 2-Adrenoceptor Function on the Course of Sepsis
Current Pharmacogenomics and Personalized Medicine Advances in the Analysis of Hepatitis C Virus Specific T Cell Responses
Mini-Reviews in Medicinal Chemistry Somatic Drugs for Psychiatric Diseases: Aspirin or Simvastatin for Depression?
Current Neuropharmacology Vascular Endothelial Growth Factor in Central Nervous System Injuries – A Vascular Growth Factor Getting Nervous?
Current Neurovascular Research Patent Selections
Recent Patents on Endocrine, Metabolic & Immune Drug Discovery Applications of Animal Models of Infectious Arthritis in Drug Discovery:A focus on Alphaviral Disease
Current Drug Targets Neuropathic Pain: Is the End of Suffering Starting in the Gene Therapy?
Current Drug Targets Expediting Molecular Translational Approach of Mesenchymal Stem Cells in COVID-19 Treatment
Current Stem Cell Research & Therapy Metabolic-Inflammatory Changes, and Accelerated Atherosclerosis in HIV Patients: Rationale for Preventative Measures
Current Medicinal Chemistry Hepatitis C Virus Exposure and Infection in the Perinatal Period
Current Pediatric Reviews Editorial: Adverse Drug Reactions – Preventable or Unexpected?
Current Drug Safety Role of Cyclic Nucleotide Gated Channels in Stress Management in Plants
Current Genomics Nightmares and the Cannabinoids
Current Neuropharmacology Antibody-Based Targeted Interventions for the Diagnosis and Treatment of Skin Cancers
Anti-Cancer Agents in Medicinal Chemistry